Related Experiment Video
Updated: Aug 26, 2026

Isolation and Culture of Primary Human Mammary Epithelial Cells
Published on: May 3, 2024
Cyclin-dependent kinase 6 inhibits proliferation of human mammary epithelial cells
Joseph J Lucas1, Joanne Domenico, Erwin W Gelfand
1Division of Cell Biology, Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO 80206, USA. lucasj@njc.org
Abstract:
Many defects in cancer cells are in molecules regulating G(1)-phase cyclin-dependent kinases (cdks), which are responsible for modulating the activities of Rb family growth-suppressing proteins. Models for understanding how such defects affect proliferation assume that cdks are responsible for sequentially phosphorylating, and hence inactivating, the growth-suppressing functions of Rb family proteins, thus promoting cell cycle progression. However, cdks also play a role in formation of growth-suppressing forms of pRb family molecules, including the "hypophosphorylated" species of pRb itself. Here, it is shown that normal human mammary epithelial cells have a high amount of cdk6 protein and activity, but all breast tumor-derived cell lines analyzed had reduced levels, with several having little or no cdk6. Immunohistochemical studies showed reduced levels of cdk6 in breast tumor cells as compared with normal breast tissue in vivo. Cdk6 levels in two breast tumor cell lines were restored to those characteristic of normal human mammary epithelial cells by DNA transfection. The cells had a reduced growth rate compared with parental tumor cells; cells that lost ectopic expression of cdk6 reverted to the faster growth rate of parental cells. Cell lines with restored cdk6 levels accumulated higher amounts of the Rb family protein p130 as well as E2F4, a suppressing member of the E2F family of transcription factors, in their nuclei. The results suggest that cdk6 restrains rather than stimulates breast epithelial cell proliferation and that its loss or down-regulation could play a role in breast tumor development.
Insights
Loss of cdk6 protein, which normally restrains cell growth, is observed in breast tumors. Restoring cdk6 levels in cancer cells reduced their proliferation, suggesting cdk6
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Defects in G(1)-phase cyclin-dependent kinases (cdks) are common in cancer.
- Current models suggest cdks promote cell cycle progression by inactivating growth-suppressing proteins like Rb.
- However, cdks also contribute to the formation of growth-suppressing Rb complexes.
Purpose of the Study:
- To investigate the role of cdk6 in breast epithelial cell proliferation and breast tumor development.
- To determine if cdk6 functions as a growth suppressor in human mammary epithelial cells.
Main Methods:
- Quantification of cdk6 protein and activity in normal and breast tumor-derived cell lines.
- Immunohistochemical analysis of cdk6 expression in vivo.
- Restoration of cdk6 levels via DNA transfection in tumor cell lines.
- Assessment of cell proliferation rates and Rb family protein/E2F4 nuclear accumulation.
Main Results:
- Normal human mammary epithelial cells exhibit high cdk6 levels, while breast tumor cell lines show significantly reduced or absent cdk6.
- Restoring cdk6 in tumor cells decreased their growth rate.
- Loss of restored cdk6 expression led to a return to faster proliferation.
- Restored cdk6 increased nuclear accumulation of p130 and E2F4.
Conclusions:
- Cdk6 acts as a restraint on breast epithelial cell proliferation, contrary to some models of cdk function.
- Down-regulation or loss of cdk6 may contribute to the development of breast tumors.
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
Positive Regulator Molecules
Positive Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Abnormal Proliferation

